Related Experiment Videos
[Autoimmune pancreatitis: a new clinical entity]
1Massachusetts General Hospital-Harvard Medical School, Medicine-GI Unit, Jackson 802, 55 Fruit Street, Boston, MA 02114, USA. mmaillard@partners.org
Revue Medicale Suisse
|August 10, 2006
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Real-world Effectiveness of Advanced Therapies in Microscopic Colitis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025
Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease.
European journal of gastroenterology & hepatology·2022
Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland.
Therapeutic advances in gastroenterology·2022
Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case Series.
Journal of Crohn's & colitis·2021
Adherence to Recommendations and Quality of Endoscopic Colorectal Cancer Surveillance in Long-Standing Ulcerative Colitis.
Inflammatory intestinal diseases·2021
[Erythema multiforme : target deciphering].
Revue medicale suisse·2026
[Integrative medicine : a structured referral framework for general practitioners].
Revue medicale suisse·2026
[Targeted therapy for ultra-rare diseases].
Revue medicale suisse·2026
[Inherited metabolic diseases in adults : from diagnosis to treatment].
Revue medicale suisse·2026
[Cardiogenetics in clinical practice : challenges, indications, and perspectives].
Revue medicale suisse·2026
[Genetic medicine illustrated by three key syndromes].
Revue medicale suisse·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026